Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 8, Issue 1, pp. 146-154
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 28, 2019
- Revision received September 20, 2019
- Accepted November 8, 2019
- Published first November 12, 2019.
Article Versions
- Previous version (November 12, 2019 - 06:31).
- Previous version (December 13, 2019 - 05:44).
- You are viewing the most recent version of this article.
Copyright & Usage
©2019 American Association for Cancer Research.
Author Information
- Jiefei Han1,#,
- Jianchun Duan1,#,
- Hua Bai1,
- Yuqi Wang2,
- Rui Wan1,
- Xin Wang1,
- Si Chen2,
- Yanhua Tian1,
- Di Wang1,
- Kailun Fei1,
- Zhuoran Yao1,
- Shuhang Wang3,
- Zhimin Lu4,5,*,
- Zhijie Wang1,*, and
- Jie Wang1,*
- 1State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- 2Geneplus-Beijing Institute, Beijing, China.
- 3GCP Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- 4State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- 5Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- ↵*Corresponding Authors:
Jie Wang, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Pan-jia-yuan South Lane, Chaoyang District, Beijing 100021, China. Phone: 86-13910704669; Fax: 86-10-88196562; E-mail: zlhuxi{at}163.com; Zhijie Wang, Phone: 86-10-87788029; Fax: 86-10-87788027; E-mail: Jie_969{at}163.com; and Zhimin Lu, Phone: 86-13241839116; Fax: 86-10-67787079; E-mail: zlumdacc{at}yahoo.com
↵#J. Han and J. Duan contributed equally to this article.
January 2020
Volume 8, Issue 1
Volume 8, Issue 1
TCR Repertoire Diversity of Peripheral PD-1+CD8+ T Cells Predicts Clinical Outcomes after Immunotherapy in Patients with Non–Small Cell Lung Cancer
Jump to section
Advertisement